"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Descriptor ID |
D008545
|
| MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
| Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 11 | 0 | 11 |
| 1997 | 8 | 0 | 8 |
| 1998 | 10 | 0 | 10 |
| 1999 | 9 | 0 | 9 |
| 2000 | 14 | 1 | 15 |
| 2001 | 13 | 3 | 16 |
| 2002 | 17 | 3 | 20 |
| 2003 | 14 | 2 | 16 |
| 2004 | 14 | 2 | 16 |
| 2005 | 16 | 2 | 18 |
| 2006 | 29 | 2 | 31 |
| 2007 | 21 | 1 | 22 |
| 2008 | 27 | 3 | 30 |
| 2009 | 29 | 2 | 31 |
| 2010 | 23 | 5 | 28 |
| 2011 | 38 | 3 | 41 |
| 2012 | 33 | 3 | 36 |
| 2013 | 33 | 5 | 38 |
| 2014 | 37 | 5 | 42 |
| 2015 | 36 | 0 | 36 |
| 2016 | 24 | 0 | 24 |
| 2017 | 51 | 1 | 52 |
| 2018 | 27 | 1 | 28 |
| 2019 | 41 | 0 | 41 |
| 2020 | 33 | 5 | 38 |
| 2021 | 26 | 1 | 27 |
| 2022 | 31 | 0 | 31 |
| 2023 | 34 | 0 | 34 |
| 2024 | 24 | 5 | 29 |
| 2025 | 16 | 1 | 17 |
| 2026 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial. Clin Cancer Res. 2026 Jun 15; 32(12):2381-2390.
-
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. J Immunother Cancer. 2026 May 04; 14(5).
-
A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part I-Epidemiology and Overview of Common Pediatric Head and Neck Tumors. Ann Plast Surg. 2026 May 01; 96(5):435-443.
-
The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells. Oncotarget. 2026 03 27; 17(1):78-89.
-
MHC class I on target cells regulates CD4+ T cell-mediated immunity. Nat Immunol. 2026 May; 27(5):1000-1012.
-
Translating ctDNA into cutaneous melanoma care: An international expert survey. Eur J Cancer. 2026 May 15; 239:116676.
-
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma. Melanoma Res. 2026 Jun 01; 36(3):189-196.
-
Cutaneous Melanoma: A Review. JAMA. 2025 Dec 16; 334(23):2113-2125.
-
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clin Cancer Res. 2025 Dec 15; 31(24):5225-5236.
-
Early genetic evolution of driver mutations in uveal melanoma. Nat Commun. 2025 Dec 12; 16(1):11322.